QIAGEN has announced a collaboration agreement with AstraZeneca PLC for the co-development and commercialization of a liquid biopsy-based companion diagnostic to be paired with IRESSA, AstraZeneca’s targeted therapy for non-small cell lung cancer (NSCLC).
Tags: companion diagnostics, lung cancer
Show per page
2 of 26 Page
1 2 3 ... Next
Popular tags in SelectScience